Denali Therapeutics Inc. SEC filings DNLI

Denali Therapeutics Inc. has 789 filings in SEC EDGAR's recent list, going back to Sep 8, 2017. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Denali Therapeutics Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 3, 2026 Nov 3, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Acquisition or sale of assets
Jul 28, 2026 Jul 27, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Jun 18, 2026 Jun 12, 2026
8-K Current report
Shareholder vote results
Jun 4, 2026 Jun 3, 2026
8-K Current report
Regulation FD disclosure
May 22, 2026 May 21, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
DEFA14A Additional proxy material Apr 21, 2026 —
ARS Annual report to shareholders Apr 21, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 21, 2026 Dec 31, 2025
8-K Current report
Agreement ended
Apr 3, 2026 Apr 3, 2026
8-K Current report
New debt, Regulation FD disclosure
Mar 31, 2026 Mar 27, 2026
8-K Current report
Regulation FD disclosure
Mar 25, 2026 Mar 25, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
S-8 Employee stock plan registration Feb 26, 2026 —
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Regulation FD disclosure
Jan 6, 2026 Jan 6, 2026
8-K Current report
Material agreement, Other events
Dec 10, 2025 Dec 9, 2025
424B5 Prospectus supplement Dec 10, 2025 —
424B5 Prospectus supplement Dec 9, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Dec 4, 2025 Dec 4, 2025
8-K Current report
Material agreement
Dec 4, 2025 Dec 4, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Regulation FD disclosure
Oct 14, 2025 Oct 13, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
8-K Current report
Regulation FD disclosure
Jul 7, 2025 Jul 7, 2025
8-K Current report
Material agreement, Shareholder vote results
Jun 3, 2025 Jun 3, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
ARS Annual report to shareholders Apr 17, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 17, 2025 —
DEF 14A Proxy statement Apr 17, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Apr 2, 2025 Apr 2, 2025
8-K Current report
Regulation FD disclosure
Mar 5, 2025 Mar 5, 2025
S-8 Employee stock plan registration Feb 27, 2025 —
8-K Current report
Material agreement, Agreement ended, Results of operations
Feb 27, 2025 Feb 27, 2025
S-3ASR Automatic shelf registration Feb 27, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
8-K Current report
Regulation FD disclosure
Jan 7, 2025 Jan 6, 2025
8-K Current report
Bylaw or fiscal year change
Nov 18, 2024 Nov 12, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Regulation FD disclosure
Oct 10, 2024 Oct 10, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 1, 2024 Aug 1, 2024
8-K Current report
Shareholder vote results
May 31, 2024 May 31, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 18, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 18, 2024 —
DEF 14A Proxy statement Apr 18, 2024 Dec 31, 2023
S-3ASR Automatic shelf registration Mar 22, 2024 —
D Filing Mar 1, 2024 —
S-8 Employee stock plan registration Feb 28, 2024 —
10-K Annual report Feb 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 27, 2024 Feb 27, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Feb 27, 2024 Feb 27, 2024
8-K Current report
Regulation FD disclosure
Feb 16, 2024 Feb 16, 2024
8-K Current report
Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Material agreement
Aug 21, 2023 Aug 17, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Other events
Jun 20, 2023 Jun 20, 2023
8-K Current report
Other events
Jun 5, 2023 Jun 5, 2023
8-K Current report
Shareholder vote results
Jun 2, 2023 Jun 1, 2023
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 8, 2023 May 8, 2023
ARS Annual report to shareholders Apr 18, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 18, 2023 —
DEF 14A Proxy statement Apr 18, 2023 —
S-8 Employee stock plan registration Feb 27, 2023 —
10-K Annual report Feb 27, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 27, 2023 Feb 27, 2023
8-K Current report
Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Material agreement, Other events
Oct 20, 2022 Oct 19, 2022
424B5 Prospectus supplement Oct 20, 2022 —
8-K Current report
Results of operations, Other events
Oct 18, 2022 Oct 18, 2022
424B5 Prospectus supplement Oct 18, 2022 —
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
8-K Current report
Regulation FD disclosure
Jul 5, 2022 Jul 4, 2022
8-K Current report
Shareholder vote results
Jun 3, 2022 Jun 2, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 19, 2022 —
DEF 14A Proxy statement Apr 19, 2022 Jun 2, 2022
8-K Current report
Officer or director change
Mar 16, 2022 Mar 14, 2022
8-K Current report
Material agreement
Feb 28, 2022 Feb 28, 2022
S-3ASR Automatic shelf registration Feb 28, 2022 —
S-8 Employee stock plan registration Feb 28, 2022 —
10-K Annual report Feb 28, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 28, 2022 Feb 28, 2022
8-K Current report
Regulation FD disclosure
Feb 14, 2022 Feb 14, 2022
8-K Current report
Other events
Feb 10, 2022 Feb 10, 2022
8-K Current report
Officer or director change
Feb 7, 2022 Feb 7, 2022
8-K Current report
Regulation FD disclosure
Jan 10, 2022 Jan 10, 2022
8-K Current report
Regulation FD disclosure
Nov 17, 2021 Nov 17, 2021
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
10-Q Quarterly report Aug 4, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 4, 2021 Aug 4, 2021
8-K Current report
Other events
Jul 26, 2021 Jul 25, 2021
8-K Current report
Shareholder vote results
Jun 4, 2021 Jun 2, 2021
10-Q Quarterly report May 5, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 3, 2021 May 3, 2021
DEFA14A Additional proxy material Apr 22, 2021 —
DEF 14A Proxy statement Apr 22, 2021 Jun 2, 2021
S-8 Employee stock plan registration Feb 26, 2021 —
10-K Annual report Feb 26, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
8-K Current report
Other events
Feb 12, 2021 Feb 12, 2021
8-K/A Amended current report
Officer or director change
Feb 10, 2021 Jan 8, 2021
8-K Current report
Other events
Feb 5, 2021 Feb 4, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 11, 2021 Jan 8, 2021
8-K Current report
Other events
Nov 10, 2020 Nov 10, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Oct 7, 2020 Oct 4, 2020
8-K Current report
Officer or director change
Aug 20, 2020 Aug 17, 2020
8-K/A Amended current report
Shareholder vote results
Aug 20, 2020 Jun 3, 2020
10-Q Quarterly report Aug 7, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 7, 2020 Aug 7, 2020
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Aug 6, 2020 Aug 5, 2020
8-K Current report
Shareholder vote results
Jun 8, 2020 Jun 3, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations, Other events
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Apr 22, 2020 —
DEF 14A Proxy statement Apr 22, 2020 Jun 3, 2020
8-K Current report
Results of operations, Other events
Apr 2, 2020 Apr 2, 2020
S-8 Employee stock plan registration Feb 28, 2020 —
10-K Annual report Feb 27, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 27, 2020 Feb 27, 2020
8-K Current report
Material agreement, Other events
Jan 29, 2020 Jan 28, 2020
424B5 Prospectus supplement Jan 29, 2020 —
8-K Current report
Results of operations, Other events
Jan 27, 2020 Jan 27, 2020
424B5 Prospectus supplement Jan 27, 2020 —
8-K Current report
Other events
Jan 14, 2020 Jan 14, 2020
10-Q Quarterly report Nov 6, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 6, 2019 Nov 6, 2019
UPLOAD Letter from the SEC Oct 7, 2019 —
CORRESP Letter to the SEC Sep 11, 2019 —
UPLOAD Letter from the SEC Aug 16, 2019 —
10-Q Quarterly report Aug 6, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 6, 2019 Aug 6, 2019
CORRESP Letter to the SEC Jul 16, 2019 —
UPLOAD Letter from the SEC Jul 2, 2019 —
8-K Current report
Shareholder vote results
Jun 3, 2019 May 30, 2019
10-Q Quarterly report May 8, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 8, 2019 May 8, 2019
DEFA14A Additional proxy material Apr 18, 2019 —
DEF 14A Proxy statement Apr 18, 2019 May 30, 2019
CT ORDER Filing Mar 25, 2019 —
S-3ASR Automatic shelf registration Mar 12, 2019 —
S-8 Employee stock plan registration Mar 12, 2019 —
10-K Annual report Mar 12, 2019 Dec 31, 2018
8-K Current report
Results of operations
Mar 12, 2019 Mar 12, 2019
CT ORDER Filing Feb 21, 2019 —
8-K Current report
Other events
Jan 4, 2019 Dec 19, 2018
10-Q/A Amended quarterly report Dec 6, 2018 Jun 30, 2018
8-K Current report
Other events
Nov 19, 2018 Nov 19, 2018
CT ORDER Filing Nov 19, 2018 —
10-Q Quarterly report Nov 8, 2018 Sep 30, 2018
8-K Current report
Results of operations, Officer or director change
Nov 8, 2018 Nov 6, 2018
8-K Current report
Material agreement, Regulation FD disclosure
Nov 1, 2018 Oct 29, 2018
10-Q Quarterly report Aug 9, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 9, 2018 Aug 9, 2018
8-K Current report
Other events
Aug 1, 2018 Aug 1, 2018
CT ORDER Filing Jul 17, 2018 —
10-K/A Amended annual report Jul 13, 2018 Dec 31, 2017
8-K Current report
Shareholder vote results
Jun 15, 2018 Jun 13, 2018
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
May 30, 2018 May 30, 2018
10-Q Quarterly report May 11, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 11, 2018 May 11, 2018
8-K Current report
Material agreement, New debt
May 7, 2018 May 2, 2018
DEFA14A Additional proxy material Apr 26, 2018 —
DEF 14A Proxy statement Apr 26, 2018 Jun 13, 2018
10-K Annual report Mar 19, 2018 Dec 31, 2017
8-K Current report
Results of operations, Officer or director change
Mar 19, 2018 Mar 16, 2018
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 5, 2018 Jan 3, 2018
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Dec 12, 2017 Dec 12, 2017
S-8 Employee stock plan registration Dec 8, 2017 —
424B4 Prospectus Dec 8, 2017 —
CT ORDER Filing Dec 8, 2017 —
EFFECT Filing Dec 7, 2017 —
S-1/A Amended registration statement Dec 7, 2017 —
CORRESP Letter to the SEC Dec 4, 2017 —
CORRESP Letter to the SEC Dec 4, 2017 —
CERTNAS Auto-generated paper document Dec 1, 2017 —
8-A12B Form 8-a12b Nov 30, 2017 —
CORRESP Letter to the SEC Nov 27, 2017 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
DNLI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1714899

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.